Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells
Tomoyuki Koga, Isaac A. Chaim, Jorge A. Benítez, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in glioma
Erik Jung, Matthias Osswald, Miriam Ratliff, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 112
The Many Facets of Therapy Resistance and Tumor Recurrence in Glioblastoma
Anshika Goenka, Deanna Tiek, Xiao Song, et al.
Cells (2021) Vol. 10, Iss. 3, pp. 484-484
Open Access | Times Cited: 110
Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy
Matin Chehelgerdi, Fereshteh Behdarvand Dehkordi, Mohammad Chehelgerdi, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 71
Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective
Radhika Mathur, Qixuan Wang, Patrick G. Schupp, et al.
Cell (2024) Vol. 187, Iss. 2, pp. 446-463.e16
Open Access | Times Cited: 71
Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go
Ruggero De Maria Marchiano, Gabriele Di Sante, Geny Piro, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 3, pp. 216-216
Open Access | Times Cited: 83
Sequential fate-switches in stem-like cells drive the tumorigenic trajectory from human neural stem cells to malignant glioma
Xiaofei Wang, Ran Zhou, Yanzhen Xiong, et al.
Cell Research (2021) Vol. 31, Iss. 6, pp. 684-702
Open Access | Times Cited: 65
The current landscape of immunotherapy for pediatric brain tumors
Eugene Hwang, Elias Sayour, Catherine Flores, et al.
Nature Cancer (2022) Vol. 3, Iss. 1, pp. 11-24
Closed Access | Times Cited: 40
Rat and Mouse Brain Tumor Models for Experimental Neuro-Oncology Research
Upasana Sahu, Rolf F. Barth, Yoshihiro Otani, et al.
Journal of Neuropathology & Experimental Neurology (2022) Vol. 81, Iss. 5, pp. 312-329
Open Access | Times Cited: 31
Functional genomics and the future of iPSCs in disease modeling
Imogen Brooks, Cristina M. Garrone, Caoimhe Kerins, et al.
Stem Cell Reports (2022) Vol. 17, Iss. 5, pp. 1033-1047
Open Access | Times Cited: 29
PTEN deficiency leads to proteasome addiction: a novel vulnerability in glioblastoma
Jorge A. Benítez, Darren Finlay, Anthony S. Castanza, et al.
Neuro-Oncology (2021)
Open Access | Times Cited: 35
Pharmacological targeting of the tumor–immune symbiosis in glioblastoma
Lizhi Pang, Fatima Khan, Madeline Dunterman, et al.
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 8, pp. 686-700
Open Access | Times Cited: 24
Leveraging extrachromosomal DNA to fine-tune trials of targeted therapy for glioblastoma: opportunities and challenges
Imran Noorani, Paul S. Mischel, Charles Swanton
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 11, pp. 733-743
Closed Access | Times Cited: 24
RNA splicing analysis deciphers developmental hierarchies and reveals therapeutic targets in adult glioma
Xiao Song, Deanna Tiek, Shunichiro Miki, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 11
Open Access | Times Cited: 5
SMARCB1 loss interacts with neuronal differentiation state to block maturation and impact cell stability
Alison D. Parisian, Tomoyuki Koga, Shunichiro Miki, et al.
Genes & Development (2020) Vol. 34, Iss. 19-20, pp. 1316-1329
Open Access | Times Cited: 36
Biomaterial-based in vitro 3D modeling of glioblastoma multiforme
Tanvir Ahmed
Cancer Pathogenesis and Therapy (2023) Vol. 1, Iss. 3, pp. 177-194
Open Access | Times Cited: 11
18 Pathology of Spinal Cord Neoplasms

(2025)
Closed Access
The Organoid Era Permits the Development of New Applications to Study Glioblastoma
Francesco Andreatta, Giulia Beccaceci, Nicolò Fortuna, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3303-3303
Open Access | Times Cited: 30
Human induced pluripotent stem cell engineering establishes a humanized mouse platform for pediatric low-grade glioma modeling
Corina Anastasaki, Jit Chatterjee, Olivia Cobb, et al.
Acta Neuropathologica Communications (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 18
Modeling Human Brain Tumors and the Microenvironment Using Induced Pluripotent Stem Cells
Zahraa I. Khamis, Drishty B. Sarker, Yu Xue, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1253-1253
Open Access | Times Cited: 10
The function of histone methylation and acetylation regulators in GBM pathophysiology
Colin McCornack, Timothy Woodiwiss, Angela Hardi, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
Interconversion of Cancer Cells and Induced Pluripotent Stem Cells
Drishty B. Sarker, Yu Xue, Faiza Mahmud, et al.
Cells (2024) Vol. 13, Iss. 2, pp. 125-125
Open Access | Times Cited: 3
Advancing Glioblastoma Research with Innovative Brain Organoid-Based Models
Cátia D. Correia, Sofia M. Calado, Alexandro Matos, et al.
Cells (2025) Vol. 14, Iss. 4, pp. 292-292
Open Access
Autologous humanized mouse models of iPSC-derived tumors enable characterization and modulation of cancer-immune cell interactions
Gaël Moquin‐Beaudry, Basma Benabdallah, Damien Maggiorani, et al.
Cell Reports Methods (2022) Vol. 2, Iss. 1, pp. 100153-100153
Open Access | Times Cited: 15
Pioneering models of pediatric brain tumors
Florina Grigore, Serena Johanna Yang, Clark C. Chen, et al.
Neoplasia (2023) Vol. 36, pp. 100859-100859
Open Access | Times Cited: 8
TERT promoter C228T mutation in neural progenitors confers growth advantage following telomere shortening in vivo
Shunichiro Miki, Tomoyuki Koga, Andrew McKinney, et al.
Neuro-Oncology (2022) Vol. 24, Iss. 12, pp. 2063-2075
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top